Relief of Lumbar Spinal Stenosis Symptoms
Launched by DISKAPI TEACHING AND RESEARCH HOSPITAL · Apr 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two treatments for people suffering from lumbar spinal stenosis, a condition that causes narrowing of the spinal canal, which can lead to pain in the lower back and legs. The trial is comparing a type of injection called a caudal epidural steroid injection with another treatment known as caudal epidural pulsed radiofrequency stimulation. The goal is to see which method provides better relief from pain and reduces the need for medication.
To participate in the study, individuals should be between 65 and 74 years old and have been experiencing back and leg pain for at least three months due to lumbar spinal stenosis. However, people who have had previous back surgery, are pregnant, have certain serious health issues, or are taking specific medications may not be eligible. Those who join the trial can expect to receive one of the two treatments and will be monitored for pain relief and any side effects. This trial is currently recruiting participants, and it's a great opportunity for those looking for effective ways to manage their pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Among the patients with lumbar spinal stenosis findings and narrowing of the spinal canal detected by examination and imaging methods, those whose back and leg pain persists for at least 3 months
- Exclusion Criteria:
- • Previous lumbar surgery, pregnancy, history of ongoing malignant disease, autoimmune diseases, active infection of the injection site, hematologic disorders, antiplatelet drug use
About Diskapi Teaching And Research Hospital
Diskapi Teaching and Research Hospital is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and education. As a leading sponsor of clinical trials, the hospital is committed to enhancing patient outcomes and contributing to medical knowledge across various disciplines. With a focus on rigorous scientific protocols and ethical standards, Diskapi leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct trials that explore new therapeutic options and improve existing treatments. Through collaboration with healthcare professionals and researchers, Diskapi aims to translate research findings into practical applications that benefit patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, , Turkey
Ankara, Türkiye, Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Ömer Taylan T Akkaya, Prof
Principal Investigator
Department of Algology, Ankara Etlik City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported